Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Insight Lifetech CoSHSE:688712 -0.09%31 ROE % is 14.21% as of Mar. 2026. GuruFocus rates SHSE:688712 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 798 Medical Devices & Instruments companies, Insight Lifetech Co ranks better than 76.69% on this metric.
The historical rank and industry rank for Insight Lifetech Co's ROE % or its related term are showing as below:
SHSE:688712'
s ROE % Range Over the Past 10 Years
Min: -88.9 Med: -28.95 Max: 10.85
Current: 10.85
During the past 7 years, Insight Lifetech Co's highest ROE % was 10.85%. The lowest was -88.90%. And the median was -28.95%.
SHSE:688712's ROE % is ranked better than 76.69% of 798
companies
in the Medical Devices & Instruments industry
Industry Median: 2.51
vs SHSE:688712: 10.85
Insight Lifetech Co (SHSE:688712) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Insight Lifetech Co ROE % Related Terms
Insight Lifetech Co ROE % Historical Data
* Premium members only.
The historical data trend for Insight Lifetech Co's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Insight Lifetech Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insight Lifetech Co ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Insight Lifetech Co's ROE % distribution charts can be found below:
* The bar in red indicates where Insight Lifetech Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Insight Lifetech Co (SHSE:688712) has a ROE % of 14.21% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Insight Lifetech Co and its competitors. According to the industry distribution chart, Insight Lifetech Co ranks #186 out of 798 companies in the Medical Devices & Instruments industry, placing it in the top 23.3%.
Is Insight Lifetech Co's ROE % too high?
Insight Lifetech Co's current ROE % is 14.21%. The Medical Devices & Instruments industry median ROE % is 2.51. Insight Lifetech Co's value of 14.21% is 466.1% above this industry median. Based on the distribution chart, Insight Lifetech Co ranks #186 out of 798 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Insight Lifetech Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Insight Lifetech Co's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Insight Lifetech Co ranks #186 out of 798 companies for ROE %. This places Insight Lifetech Co in the top 23% of its industry — outperforming the majority of peers. The industry median ROE % is 2.51. Insight Lifetech Co's value of 14.21% is 466.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.51, based on 798 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Insight Lifetech Co's current ROE % of 14.21% is 466.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Insight Lifetech Co and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Insight Lifetech Co's current ROE % is 14.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insight Lifetech Co stock overvalued right now?
Insight Lifetech Co (SHSE:688712) has a current ROE % of 14.21%. The current ROE % is 14.21% and 466.1% above the Medical Devices & Instruments industry median of 2.51. Insight Lifetech Co's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Insight Lifetech Co (SHSE:688712), the current ROE % is 14.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressMinzhi Street, Hongrongyuan North Station Center, Tower A 2102, North Station Community, Longhua District, Guangdong Province, Shenzhen, CHN, 518000
Insight Lifetech Co Ltd is a medtech company. It is engaged in the research and development, production, and sale of medical devices used in the diagnosis and treatment of cardiovascular diseases. The company's core products are the TruePhysio pressure microcatheter and VivoCardio FFR system.
31GF Score
Get the complete analysis for SHSE:688712
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688712 has been successfully added to your 
